重型病毒性肝炎

方法：总结分析167例重型病毒性肝炎资料。

Methods : Clinical data of 167 cases with SVH were gathered fro this study .

结论预防性抗感染治疗可降低重型病毒性肝炎SBP的发生率，缩短住院天数，提高存活率。

Conclusion Preventive antibacterial treatment may reduce the SBP frequency and the hospitalized days , and increase the survival rate in the patients with severe hepatitis .

伊曲康唑联合两性霉素B治疗重型病毒性肝炎合并胸膜曲霉菌感染1例

Severe viral hepatitis complicated with pleural aspergillus infection treated with itraconazole and amphotericin B

前列腺素E1脂微球制剂治疗重型病毒性肝炎28例疗效观察

Therapeutic efficacy of lipo PGE_1 injection for 28 cases with severe viral hepatitis

综合疗法治疗重型病毒性肝炎的血液流变学及血浆血栓素B2的观察

The changes of Hemorrheology and Plasma Thromboxane B_2 in the Patients with Severe Viral Hepatitis during the Combined Therapy

重型病毒性肝炎中丁型肝炎病毒的检测重型肝炎病人中乙型肝炎病毒C基因变异研究

Studies on Hepatitis D Virus infection in Fulminant Hepatitis B Patients HEPATITIS B VIRUS CORE GENE MUTATIONS IN FULMINANT HEPATITIS

PGE1治疗慢性重型病毒性肝炎的临床研究

Clinical Studies on Treatment of Chronic Severe Viral Hepatitis with PGE1

重型病毒性肝炎患者PBMCs中TNF-α、IL-1α和IL-4mRNA表达水平及其意义探讨

The expression levels of TNF α、 IL 1 α and IL 4 mRNA in PBMCs and their significance in severe viral hepatitis

对22例用综合疗法治疗的重型病毒性肝炎（重肝）患者进行了血液流变学观察，18例病人还检测了血浆血栓素B2（TXB2）和内毒素。

22 patients with severe viral hepatitis ( SVH ) were treated with combined therapy , indices of hemorrheology and plasma ( TXB2 ) of 18 patients were determined .

探讨血浆置换疗法时重型病毒性肝炎患者血清中HBV-DNA负荷量的变化及其对临床的影响。

Objective To study the affect of serum HBV-DNA changed by plasma exchange ( PE ) treating patients with fulminant hepatitis and the relation to the clinical significance .

内毒素及h-EGF检测与重型病毒性肝炎预后的临床研究

The Clinical Study of Endotoxin and h-EGF Examine in the Severe Hepatitis Prognosis

目的探讨提高早期重型病毒性肝炎（SVH）治疗效果的方法。

Objective To explore the methods of enhanced therapeutic effects for the early severe viral hepatitis ( SVH ) .

目的：①探讨白细胞介素18（IL-18）等细胞因子在慢性重型病毒性肝炎（慢重肝）早期病变过程中的作用；

Objectives To determine whether there is a correlation of serum interleukin-18 ( IL-18 ) level with the severity of chronic severe viral hepatitis ( CSVH ) in the course of the disease evolution .

目的分析重型病毒性肝炎（SVH）预后的影响因素，提出护理对策。

Objective To analyze the influence factors of prognosis of severe viral hepatitis ( SVH ), and to propose the nursing countermeasures .

方法：对46例慢性重型病毒性肝炎并低钠血症及腹水患者给予补钠治疗，观察血钠、尿钠、腹水钠、24h尿量的变化。

Methods : 46 cases of viral chronic severe hepatitis with hyponatremia and ascites were supplied with sodium , and the changes of concertration of sodium in blood , ascites , urine and its volume were observed during 24 hours .

采用荧光法检测38例慢性重型病毒性肝炎（慢重肝）、22例急性肝炎和20名正常人血浆和尿液脂质过氧化物（LPO）含量。

The plasma and urinary lipid peroxides ( LPO ) levels were measured by fluorometric assay in 38 patients with chronic severe viral hepatitis ( CSVH ), 22 patients with acute hepatitis ( AH ) and 20 healthy controls .

方法选择40例在内科综合性治疗的基础上加用血浆置换治疗的重型病毒性肝炎住院患者，观察其在血浆置换治疗前后血清中HBV-DNA负荷量的变化及肝功能生化指标。

Methods 40 patients with fulminant hepatitis which was hospitalized were treated by PE . The HBV-DNA level and liver function before and after PE therapy were examined . Results The serum HBV-DNA level was decreased after PE therapy .

目的探讨白细胞介素18（IL18）、一氧化氮（NO）在慢性重型病毒性肝炎（慢重肝）早期中的作用以及N乙酰半胱氨酸（NAC）治疗慢重肝早期对IL18和NO水平的影响。

Objective To investigate whether there is a correlation of serum interleukin 18 ( IL 18 ) and nitric oxide ( NO ) with Fulminant Hepatic Failure ( FHF ) and the effect of N acetylcysteine ( NAC ) on IL 18 and NO levels .

谷胱甘肽辅助治疗重型病毒性肝炎和肝炎肝硬化

Adjuvant treatment of severe viral hepatitis and hepatitic cirrhosis with glutathione

慢性重型病毒性肝炎患者的营养状况分析及营养干预

Nutrition Analysis and Intervention in Patients with Severe Chronic Viral Hepatitis

重型病毒性肝炎分期多环节药物治疗效果比较

Comparative study of multiple link drug therapy for severe viral hepatitis

前列地尔治疗重型病毒性肝炎42例

Alprostadil in the Treatment of 42 Patients with Severe Viral Hepatitis

本文对五所医院收治的重型病毒性肝炎102例进行综合分析，其中急性型29例，亚急性型73例。对临床症状、体征及实验室检查结果进行了统计分析。

Clinical analysis on 102 cases of severe hepatitis is reported .

重型病毒性肝炎酸碱失衡的多指标联合诊断

Multiple-parameter diagnosis of acid-base disturbance in patients with severe viral hepatitis

368例重型病毒性肝炎患者医院感染调查

Analysis on nosocomial infection in 368 patients with severe viral hepatitis

结肠途径治疗机治疗慢性重型病毒性肝炎的临床研究

Clinical Study of Using Colon Therapy System to Cure Severe Hepatitis

抗菌药物预防性应用在重型病毒性肝炎治疗中的价值

Application Value of Prophylactic Antibiotics Therapy in Patients with Severe Viral Hepatitis

早期预见影响重型病毒性肝炎预后的危险因素

Early Prediction of Risk Factors Affecting Prognosis of Severe Hepatitis

慢性重型病毒性肝炎的能量代谢及糖、蛋白质、脂肪氧化

Energy Metabolism and Substrate Oxidation in Patients with Severe Chronic Hepatitis B

人胎肝胞溶质治疗重型病毒性肝炎疗效初步观察

Effect of Human Fetal Liver Cytosol on Patients with Severe Viral Hepatitis